Clinical Trials
67 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
ESOPEC
University Hospital Schleswig-Holstein
MIMETIC
European Institute of Oncology
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
SELECT-2
Hangzhou Normal University
BLADE
University Hospital, Montpellier
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
ReMeTTI
Fondation Hôpital Saint-Joseph
Pancreas Resection for Colorectal Metastasis: Retrospective Study
Ospedale Generale Di Zona Moriggia-Pelascini
RiME
University of Kansas Medical Center
DIPLOMA
University Hospital, Montpellier
PALASS
University Hospital, Clermont-Ferrand
PANTELO
Institut Cancerologie de l'Ouest
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)
National University Hospital, Singapore
IMMUNOGAST
Hospices Civils de Lyon
ECID
Assiut University
AVATAR
Hospital Universitario de Fuenlabrada
PROSPECT
Hospices Civils de Lyon
Role of Perfusion CT in Pancreatic Cancer
Seoul National University Hospital
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
Peking University
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
Fudan University
Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer
Peking University
TOPARP
Institute of Cancer Research, United Kingdom
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
M.D. Anderson Cancer Center
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Pancreatic Cancer Research Team
Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer
Hospital Dr Sotero del Rio
MERCURY II
Royal Marsden NHS Foundation Trust
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
MARVEL
Royal Marsden NHS Foundation Trust
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
ChineseAMS
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
ICWIP
Betta Pharmaceuticals Co., Ltd.
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China
Berry Genomics Co., Ltd.
Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC
Peking University Cancer Hospital & Institute
PanHIPEC
University Hospital Tuebingen
PREPARE
National Cancer Center, Korea
PACMI
Assistance Publique - Hôpitaux de Paris
Metformin Plus Irinotecan for Refractory Colorectal Cancer
Barretos Cancer Hospital
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
National Taiwan University Hospital
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Shanghai Chest Hospital
IRON
Nottingham University Hospitals NHS Trust
LRP1 and Colon Cancer
CHU de Reims
EVALUATE
Dr. Soetomo General Hospital
Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Anhui Provincial Hospital
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Southwest Hospital, China
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Axcentua Pharmaceuticals AB